Immuneering Corp (IMRX) › Weighted Average Diluted SharesImmuneering Corp (IMRX) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2020-12-31: 4.95M2021-12-31: 13.61M2022-12-31: 26.39M2023-12-31: 28.42M2024-12-31: 29.98M2025-12-31: 44.01M44.01M2020-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3144.01M+46.8%2026-03-06From 2025-01-012024-12-3129.98M+5.5%2026-03-06From 2024-01-012023-12-3128.42M+7.7%2025-03-20From 2023-01-012022-12-3126.39M+93.8%2024-03-01From 2022-01-012021-12-3113.61M+175.0%2023-03-06From 2021-01-012020-12-314.95M—2022-03-10From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)